Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Amgen
Age
18–80
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Adults 18 - 80 years of age.
Living in the United States.
Consented from the Inspire online platform patient community for COSMOS-DIGITAL.
Self-Reported current use of, and intention to continue for at least 30 days, one of the following medications for the indications of weight management/obesity:
Semaglutide (wegovy)
Tirzepatide (zepbound)
You may not be if
Currently receiving treatment in another investigational device or drug study, or participation in a current clinical trial.
Self-reported sensitivity/allergy to any of the components of the self-draw collection device including stainless steel or elements commonly found in stainless steel.
Self-reported fear of blood.
Self-reported circulatory conditions causing difficulty in drawing capillary blood.
Known history of bleeding diathesis or any coagulation disorder.
History of skin disorders, abnormal skin integrity or atypical skin health within the areas to be tested in the upper arm.
Clareo Health | A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss
